Biosync Scientific - redOrbit

News - Biosync Scientific

MIV Therapeutics Announces First Ever Revenues From Cardiovascular Products Approved for European and Other Markets

2007-04-17 18:00:42

MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a le

MIV Therapeutics Highlights High-Growth Business Model, Next Generation Stent Technologies and Targeted $8 Billion Market in Updated Investor Fact Sheet

2007-04-16 03:21:36

MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a l

MIV Therapeutics Announces Addition of Eight New Approved Products Following Recent Acquisition of India-Based Stent Manufacturer

2007-04-10 18:00:28

MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a le

MIV Therapeutics Announces Addition of Veteran Management Team Following Recent Acquisition of India-Based Biosync Scientific

2007-04-09 18:00:28

MIV Therapeutics Inc. (OTCBB:MIVT)(FWB:MIV), a lea

MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines

2007-04-05 18:00:37

MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a l

More News (7 articles) »